And at the peak of this gold fever, the Bendigo Stock Exchange was one of the biggest gold exchanges outside London, with more than 1,300 companies listed. But now its owner, the National Stock Exchange, has decided to shut down …
Boston Scientific Corp., the world's No. 3 maker of heart stents, said a new study suggested its drug-coated device keeps arteries open better than one sold by Johnson & Johnson. Shares of Boston Scientific rose 7.5%. Stents, …
Boston Scientific plans to argue that Guidant did not knowingly violate the agreement, according to court papers. It has also questioned whether J&J can prove it lost money. J&J's stock has soared since, while Boston Scientific's has …
BSX): Large Open-market Purchase madeby company Independent Director - ErnestMario on Aug 3rd, at stock price …
remains sluggish, and sending its shares lower on Thursday. report. Roman has a "sell" rating on the stock. Boston Scientific shares were down 12 cents at $5.21 in morning trading on the New York Stock Exchange. associated with …
The nation's biggest medical device makers - Johnson & Johnson, Boston Scientific, Medtronic and others - could ... bill that would overrule it by approving the project. TransCanada's stock was up 2.4 percent the day after the election.
You wouldn't know that medical device makers Boston Scientific and St. Jude Medical are having a tough time by checking out their stock charts alone. Boston Scientific's hovering near a 52-week high after pulling in gains of nearly …
J&J plans to collect the breakup fee by today from Guidant, which will be reimbursed by Boston Scientific as part of the purchase. Guidant shares fell $1.59, or 2.1 percent, to close at $75.19 in New York Stock Exchange composite …
Boston Scientific is headquartered in Natick, Mass., and acquired Guidant in 2006. The Justice Department said that while Guidant took corrective action to fix the defects, the company continued selling its remaining stock of defective …
Large U.S. companies spent less than expected to comply with the Sarbanes-Oxley corporate governance law last year ... included a $622 million fee paid by Guidant after it accepted Boston Scientific's takeover bid instead of Johnson & …